Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report
Mina R.
First
;Bonello F.;Gay F.;Boccadoro M.Last
2021-01-01
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
[PUBLISHED Vsn.] Mina et al - CLML 2021 - Dara for IgM MM - 1-s2.0-S2152265020305061-main.pdf
Accesso riservato
Descrizione: [Restricted access - PUBLISHED Vsn.] Mina R et al. Clin Lymphoma Myeloma Leuk . 2021 Jan;21(1):e21-e24. © 2020 Elsevier Inc. All rights reserved. Available at: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30506-1/fulltext | https://doi.org/10.1016/j.clml.2020.08.019 .
Tipo di file:
PDF EDITORIALE
Dimensione
133.59 kB
Formato
Adobe PDF
|
133.59 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
[Author Vsn] Mina et al - 2021 - CLML - Daratumumab-Based Therapy for IgM b.pdf
Accesso riservato
Descrizione: [Author Vsn. - Restricted access] Mina R et al. Clin Lymphoma Myeloma Leuk . 2021 Jan;21(1):e21-e24. © 2020 Elsevier Inc. All rights reserved. The published version is available at: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30506-1/fulltext | https://doi.org/10.1016/j.clml.2020.08.019
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
492.94 kB
Formato
Adobe PDF
|
492.94 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
[Pre-print vsn] Mina et al - 2021 - CLML - Daratumumab-Based Therapy for IgM.pdf
Accesso aperto
Descrizione: [Pre-print vsn.] Mina R et al. Clin Lymphoma Myeloma Leuk . 2021 Jan;21(1):e21-e24. © 2020 Elsevier Inc. All rights reserved. This is not the final published version. The published version is available at: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30506-1/fulltext | https://doi.org/10.1016/j.clml.2020.08.019
Tipo di file:
PREPRINT (PRIMA BOZZA)
Dimensione
496.29 kB
Formato
Adobe PDF
|
496.29 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.